iShares Biotechnology ETF $IBB Shares Acquired by Kanawha Capital Management LLC

Kanawha Capital Management LLC lifted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,767 shares of the financial services provider’s stock after purchasing an additional 124 shares during the quarter. Kanawha Capital Management LLC’s holdings in iShares Biotechnology ETF were worth $1,109,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Ramirez Asset Management Inc. acquired a new stake in shares of iShares Biotechnology ETF during the first quarter worth $26,000. Berkshire Money Management Inc. acquired a new stake in shares of iShares Biotechnology ETF during the second quarter worth $28,000. Financial Gravity Asset Management Inc. acquired a new stake in shares of iShares Biotechnology ETF during the first quarter worth $30,000. Woodside Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the first quarter valued at $31,000. Finally, Harbor Asset Planning Inc. acquired a new position in iShares Biotechnology ETF in the second quarter valued at $31,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.5%

Shares of iShares Biotechnology ETF stock opened at $154.19 on Friday. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $156.36. The business’s fifty day moving average price is $142.93 and its 200 day moving average price is $131.41.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.